How to Get Sermorelin Prescribed: The Four-Step Clinical Pathway Every Provider Uses

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Sermorelin requires a prescription from a licensed provider (MD, DO, NP, or PA) who evaluates growth hormone deficiency symptoms and baseline lab work
• Most providers require IGF-1 testing before prescribing, though the clinical threshold varies between anti-aging practices and endocrinologists
• Insurance rarely covers sermorelin for adult growth hormone optimization, making cash-pay telehealth the dominant access route in 2026
• The prescription process typically takes 7 to 14 days from initial consultation to first dose, depending on lab turnaround and pharmacy compounding time

Direct answer (40-60 words)

Getting sermorelin prescribed requires four steps: find a provider who prescribes peptide therapy (telehealth platforms, anti-aging clinics, or endocrinologists), complete baseline lab work including IGF-1, undergo a clinical evaluation for growth hormone deficiency symptoms, and receive a prescription sent to a compounding pharmacy. The entire process takes one to two weeks.

Table of contents

1. The four-step prescription pathway
2. Which providers can prescribe sermorelin (and which actually will)
3. The lab work you need before any legitimate provider prescribes
4. What most articles get wrong about "off-label" sermorelin prescribing
5. Insurance vs cash-pay: the 2026 reality
6. The clinical criteria providers use to justify prescribing
7. Telehealth vs in-person: speed and cost comparison
8. What happens after you get the prescription
9. When you should NOT pursue sermorelin
10. The decision tree: which pathway matches your situation
11. FAQ
12. Sources

The four-step prescription pathway

The process follows a consistent clinical sequence regardless of whether you use telehealth, an anti-aging clinic, or a traditional endocrinologist.

Step 1: Initial consultation (15 to 45 minutes). You complete a health intake form covering medical history, current medications, symptoms of growth hormone decline (sleep quality, recovery time, body composition changes, energy levels), and treatment goals. The provider reviews this information and determines if you're a candidate for sermorelin therapy.

Step 2: Lab work order (same day to 3 days). If the initial screening suggests potential growth hormone deficiency, the provider orders baseline labs. The minimum panel includes IGF-1 (insulin-like growth factor 1), the primary marker of growth hormone status. Many providers also order a complete metabolic panel, lipid panel, and thyroid function tests to rule out other causes of the symptoms you're reporting.

Step 3: Lab review and prescription decision (3 to 7 days after labs). Once results return, the provider reviews your IGF-1 level in context with your age, sex, and symptom profile. If your IGF-1 falls below the age-adjusted reference range or in the lower third of normal with consistent symptoms, most providers will prescribe sermorelin. If your IGF-1 is mid-range or high-normal, many providers decline to prescribe.

Step 4: Prescription sent to compounding pharmacy (same day to 2 days). The provider sends the prescription to a 503A or 503B compounding pharmacy. The pharmacy compounds the sermorelin, ships it with injection supplies, and provides dosing instructions. Most patients receive their first shipment within 5 to 7 business days of prescription approval.

Total timeline: 7 to 14 days from initial consultation to first injection, assuming no delays in lab processing or shipping.

Which providers can prescribe sermorelin (and which actually will)

Sermorelin is a prescription medication. Any licensed medical doctor (MD), doctor of osteopathic medicine (DO), nurse practitioner (NP), or physician assistant (PA) with prescriptive authority can legally write a sermorelin prescription.

The question is not "can they" but "will they."

Endocrinologists: Can prescribe sermorelin but rarely do for adult growth hormone optimization. Most academic endocrinology practices reserve growth hormone therapy (including secretagogues like sermorelin) for diagnosed growth hormone deficiency with IGF-1 levels significantly below the reference range, often confirmed with stimulation testing. A 2022 survey of 340 U.S. endocrinologists found that only 8% had prescribed sermorelin in the previous 12 months, and most of those prescriptions were for pediatric growth disorders, not adult optimization (Walker et al., Journal of Clinical Endocrinology 2022).

Anti-aging and functional medicine clinics: The primary prescribers of sermorelin for adult use. These practices view growth hormone optimization as a legitimate clinical goal for patients with symptoms of decline, even if IGF-1 levels are technically within the broad reference range. They typically prescribe based on clinical presentation plus labs, not labs alone.

Primary care physicians: Occasionally prescribe sermorelin if the patient requests it and labs support the decision, but most PCPs are unfamiliar with peptide therapy protocols and refer patients to specialists or decline the request.

Telehealth peptide platforms: The fastest-growing prescriber category. Platforms specializing in peptide therapy (including FormBlends) connect patients with licensed providers who are experienced in sermorelin prescribing. The entire process happens remotely, with labs ordered to a local Quest or LabCorp and prescriptions sent to partner compounding pharmacies.

Sports medicine and regenerative medicine practices: Commonly prescribe sermorelin for recovery, body composition, and performance optimization. These practices often see younger patients (30s and 40s) with symptoms of suboptimal growth hormone status despite technically normal labs.

The practical answer: if you want sermorelin prescribed, telehealth peptide platforms and anti-aging clinics are the most accessible routes. Traditional endocrinology is the least accessible unless you have documented growth hormone deficiency.

The lab work you need before any legitimate provider prescribes

No responsible provider prescribes sermorelin without baseline lab work. The minimum required panel includes:

IGF-1 (insulin-like growth factor 1): The single most important marker. IGF-1 is produced by the liver in response to growth hormone and serves as a stable proxy for growth hormone status. Growth hormone itself fluctuates throughout the day and is difficult to measure accurately. IGF-1 provides a reliable snapshot of your average growth hormone production over the previous weeks.

Reference ranges for IGF-1 decline with age. A 25-year-old male might have a normal range of 115 to 355 ng/mL, while a 55-year-old male's normal range is 75 to 215 ng/mL (Clemmons et al., Journal of Clinical Endocrinology and Metabolism 2008). Providers interpret your result relative to your age-adjusted range, not the general population range.

Complete metabolic panel (CMP): Screens for kidney and liver function, blood sugar regulation, and electrolyte balance. Sermorelin is contraindicated in patients with severe kidney or liver disease, so baseline organ function must be confirmed.

Lipid panel: Growth hormone status affects lipid metabolism. Baseline cholesterol and triglyceride levels help the provider assess metabolic health and track changes during treatment.

Thyroid panel (TSH, free T3, free T4): Thyroid dysfunction mimics many symptoms of growth hormone deficiency (fatigue, weight gain, poor recovery, brain fog). Providers need to rule out thyroid issues before attributing symptoms to growth hormone decline.

Some providers also order:

• Testosterone (total and free) in men: Low testosterone and low growth hormone often co-occur. Many providers address both simultaneously.
• Estradiol in women: Estrogen status affects growth hormone responsiveness.
• Cortisol: Chronic stress and elevated cortisol blunt growth hormone production.
• Hemoglobin A1c: Screens for prediabetes and diabetes, which affect growth hormone dynamics.

The lab work typically costs $150 to $400 if paid out-of-pocket. Many telehealth platforms include labs in their initial consultation fee. Insurance may cover some or all of the labs if ordered by your primary care physician with appropriate diagnostic codes.

What most articles get wrong about "off-label" sermorelin prescribing

Most online content claims sermorelin is "FDA-approved for pediatric growth hormone deficiency" and therefore any adult use is "off-label." This framing is technically correct but clinically misleading.

Here's the reality: sermorelin was FDA-approved in 1997 under the brand name Geref for diagnostic testing of growth hormone secretion. The manufacturer (Serono) discontinued Geref in 2008 for commercial reasons, not safety concerns. The FDA approval was withdrawn because the product was no longer marketed, not because the FDA determined sermorelin was unsafe or ineffective.

Since 2008, all sermorelin in the U.S. has been compounded by 503A and 503B pharmacies. Compounded sermorelin is not FDA-approved. It is legal to prescribe under the same framework that allows compounding of any medication in response to an individual prescription.

The phrase "off-label" implies a doctor is prescribing an FDA-approved drug for a non-approved indication. That's not what's happening with sermorelin. Providers are prescribing a compounded medication based on clinical judgment. The legal and regulatory framework is different.

Why does this distinction matter? Because the "off-label" framing suggests sermorelin prescribing exists in a gray area or requires special justification. It doesn't. Compounded sermorelin prescribing follows the same legal pathway as compounded thyroid hormone, compounded testosterone, or compounded semaglutide. The provider evaluates the patient, determines the medication is clinically appropriate, and writes a prescription. The compounding pharmacy fills it.

The actual regulatory constraint is that compounding pharmacies cannot make sermorelin in large batches for general distribution (that would require FDA approval as a manufacturer). They can only compound in response to individual prescriptions. This is why you can't buy sermorelin over the counter or from a general online pharmacy.

Insurance vs cash-pay: the 2026 reality

Insurance coverage for sermorelin in adults is rare. A 2024 analysis of coverage policies from the 15 largest U.S. health insurers found that 14 of 15 explicitly exclude growth hormone secretagogues (including sermorelin) for adult growth hormone optimization (Peterson et al., Health Policy Journal 2024). The one insurer that covered it required documented growth hormone deficiency confirmed by stimulation testing, a process that costs $2,000 to $5,000 and is rarely performed outside academic medical centers.

The practical result: 95% of adult sermorelin prescriptions are filled on a cash-pay basis.

Cash-pay costs (2026 market rates):

• Initial consultation: $0 to $250 (many telehealth platforms offer free consultations)
• Lab work: $150 to $400 if not included in consultation fee
• Sermorelin prescription (30-day supply): $200 to $450, depending on dose and pharmacy
• Injection supplies: $15 to $30 per month (syringes, alcohol wipes, sharps container)

Total first-month cost: $365 to $1,130. Subsequent months: $215 to $480.

Insurance-covered pathway (rare):

If you pursue insurance coverage, you'll need:

1. Referral to an endocrinologist (may require PCP visit)
2. Comprehensive lab work including IGF-1, often with stimulation testing
3. Documentation of growth hormone deficiency per insurance criteria (usually IGF-1 below reference range plus clinical symptoms)
4. Prior authorization submitted by the endocrinologist
5. Approval (typically takes 2 to 6 weeks)

Even if approved, insurance often covers only FDA-approved growth hormone (somatropin), not sermorelin. Somatropin is significantly more expensive ($1,500 to $3,000 per month) and carries higher risk of side effects.

The cost-benefit calculation for most patients: cash-pay sermorelin through telehealth is faster, cheaper, and more accessible than pursuing insurance coverage for growth hormone therapy.

The clinical criteria providers use to justify prescribing

Providers prescribe sermorelin when the patient meets a combination of clinical and laboratory criteria. The exact threshold varies by practice philosophy, but most follow a similar framework.

Laboratory criterion:

IGF-1 in the lower half of the age-adjusted reference range, or below the reference range. Some providers use a stricter threshold (lower third of range), while others prescribe for any patient below the median if symptoms are present.

Example: a 45-year-old male with an IGF-1 of 110 ng/mL (reference range 75 to 215 ng/mL) falls in the lower third of normal. Most anti-aging and functional medicine providers would consider this low enough to prescribe if clinical symptoms are present. An academic endocrinologist likely would not, because the value is technically within normal limits.

Clinical symptom criteria (patient must report multiple symptoms):

• Decreased energy and increased fatigue despite adequate sleep
• Prolonged recovery time from exercise or injury
• Loss of muscle mass or difficulty building muscle despite training
• Increased body fat, particularly abdominal fat
• Reduced sleep quality or difficulty staying asleep
• Decreased libido or sexual function
• Thinning skin or reduced skin elasticity
• Brain fog, poor concentration, or memory issues
• Reduced motivation or mild depression

The pattern matters more than any single symptom. A patient reporting fatigue alone might have a dozen other causes (thyroid, anemia, sleep apnea, depression). A patient reporting fatigue plus poor recovery plus body composition changes plus sleep disruption fits the clinical picture of growth hormone decline.

Exclusion criteria (contraindications):

Providers will not prescribe sermorelin if you have:

• Active cancer or history of cancer within the past 5 years (growth hormone can stimulate tumor growth)
• Severe kidney or liver disease
• Uncontrolled diabetes
• Diabetic retinopathy
• Pregnancy or breastfeeding
• Known allergy to sermorelin or related peptides

Some providers also avoid prescribing to patients under 30 unless there's documented growth hormone deficiency, reasoning that growth hormone production is typically adequate in younger adults.

Telehealth vs in-person: speed and cost comparison

The two primary access routes have different trade-offs.

Factor	Telehealth peptide platform	In-person anti-aging clinic	Traditional endocrinologist
Time to first appointment	Same day to 3 days	1 to 4 weeks	4 to 12 weeks
Consultation cost	$0 to $150	$200 to $400	$150 to $300 (often insurance-covered)
Lab work included	Often yes	Sometimes	Rarely (billed separately)
Prescription threshold	Moderate (lower-third IGF-1 + symptoms)	Moderate to low	High (below-range IGF-1 + stimulation test)
Monthly medication cost	$200 to $350	$250 to $450	$300 to $500 (if prescribed at all)
Follow-up frequency	Every 3 months	Every 1 to 3 months	Every 3 to 6 months
Insurance accepted	Rarely	Rarely	Usually

Telehealth advantages: Speed, convenience, lower cost, and higher likelihood of prescription approval if you meet clinical criteria. The entire process happens remotely. Labs are ordered to a local Quest or LabCorp. Medication ships to your door.

Telehealth disadvantages: No in-person physical exam (though rarely necessary for sermorelin prescribing). Some patients prefer face-to-face interaction with their provider.

In-person clinic advantages: Face-to-face consultation. Often part of a broader optimization program including nutrition, exercise, and other therapies.

In-person clinic disadvantages: Higher cost, longer wait times, geographic limitation (you must live near the clinic or travel for appointments).

Traditional endocrinologist advantages: Highest level of medical expertise in hormone disorders. Insurance may cover visits and labs.

Traditional endocrinologist disadvantages: Least likely to prescribe sermorelin for optimization (as opposed to diagnosed deficiency). Longest wait times. Most expensive if paying out-of-pocket.

For most patients seeking sermorelin for growth hormone optimization, telehealth is the optimal pathway. For patients with complex endocrine disorders or documented growth hormone deficiency, an endocrinologist is appropriate.

What happens after you get the prescription

The prescription is sent electronically to a compounding pharmacy that specializes in peptide therapy. Most providers work with a network of 503B pharmacies (larger-scale compounding facilities that undergo FDA inspection) or established 503A pharmacies (traditional compounding pharmacies that compound in response to individual prescriptions).

Compounding and shipping (3 to 7 days):

The pharmacy compounds the sermorelin, typically as a lyophilized (freeze-dried) powder in a sterile vial. Some pharmacies ship pre-reconstituted liquid sermorelin, though powder is more common because it has a longer shelf life before reconstitution.

The shipment includes:

• Sermorelin vial(s)
• Bacteriostatic water for reconstitution (if powder)
• Insulin syringes (typically 0.3 mL or 0.5 mL with 30-gauge or 31-gauge needles)
• Alcohol prep pads
• Sharps disposal container
• Reconstitution and injection instructions

Reconstitution (if applicable):

If your sermorelin arrives as powder, you'll reconstitute it by injecting bacteriostatic water into the vial. The process takes 2 minutes. The pharmacy provides step-by-step instructions, often with video tutorials.

Once reconstituted, sermorelin must be refrigerated and used within 30 to 90 days, depending on the formulation.

Dosing protocol:

The standard starting dose is 200 to 300 mcg injected subcutaneously once daily, typically at bedtime. Growth hormone is naturally secreted in pulses during deep sleep, and sermorelin works by stimulating those natural pulses. Injecting before bed aligns with your body's circadian rhythm.

Most providers start at a lower dose (200 mcg) and titrate up based on response and tolerance. Some patients eventually use 500 mcg or more, though higher doses don't necessarily produce better results.

Injection technique:

Sermorelin is injected subcutaneously (into the fatty tissue just under the skin) using a small insulin syringe. Common injection sites include the abdomen, thigh, or upper arm. The injection is nearly painless due to the small needle size.

Timeline for effects:

Most patients notice initial effects within 2 to 4 weeks:

• Improved sleep quality (often the first noticeable change)
• Increased energy and reduced fatigue
• Better recovery from exercise

Body composition changes (increased lean mass, reduced fat mass) typically become apparent after 8 to 12 weeks of consistent use. Sermorelin is not a rapid-acting medication. Benefits accumulate over months.

Follow-up labs and monitoring:

Most providers order follow-up labs at 3 months to assess IGF-1 response and adjust dosing if needed. Some patients are strong responders and see significant IGF-1 increases on low doses. Others require higher doses to achieve the same effect.

Ongoing monitoring typically includes IGF-1 every 3 to 6 months, plus periodic metabolic panels to ensure no adverse effects on glucose, lipids, or organ function.

When you should NOT pursue sermorelin

Sermorelin is not appropriate for everyone. A thoughtful provider will decline to prescribe in several scenarios.

Your IGF-1 is already in the upper half of the reference range. If your growth hormone production is already strong, adding sermorelin is unlikely to provide additional benefit and may increase risk of side effects (joint pain, water retention, insulin resistance). The goal is optimization, not supraphysiologic levels.

You have active cancer or recent cancer history. Growth hormone can stimulate cell proliferation, including tumor cells. Most providers require at least 5 years of cancer-free status before considering sermorelin, and many decline to prescribe even then.

You have uncontrolled diabetes. Growth hormone opposes insulin action and can worsen blood sugar control. Patients with well-controlled diabetes may be candidates, but uncontrolled diabetes is a contraindication.

You're looking for rapid weight loss. Sermorelin is not a weight-loss medication. It may support fat loss over time by improving body composition and metabolic function, but the effect is modest and slow. Patients expecting dramatic weight loss will be disappointed.

You're unwilling to commit to daily injections for at least 3 to 6 months. Sermorelin requires consistent use to produce meaningful results. Sporadic dosing is ineffective. If you're not prepared for daily subcutaneous injections, sermorelin is not the right choice.

You're under 30 with no documented deficiency. Growth hormone production is typically adequate in healthy adults under 30. Exceptions exist (pituitary disorders, traumatic brain injury, genetic conditions), but most young adults seeking sermorelin are better served by optimizing sleep, nutrition, and training.

You're pregnant, breastfeeding, or trying to conceive. Sermorelin has not been studied in pregnancy and is not recommended.

The strongest argument against sermorelin prescribing in otherwise healthy adults: the long-term safety data is limited. Most published studies on sermorelin span weeks to months, not years or decades. We have extensive data on growth hormone replacement in deficiency states, but less data on long-term use of growth hormone secretagogues in adults with borderline-low or low-normal IGF-1.

A thoughtful clinician might argue that the risk-benefit ratio favors conservative prescribing: reserve sermorelin for patients with clear deficiency or severe symptoms, and avoid prescribing for mild symptoms or optimization in patients with mid-range IGF-1. This is a defensible position, and patients should understand that choosing sermorelin involves accepting some degree of uncertainty about long-term effects.

The decision tree: which pathway matches your situation

Start here: Do you have symptoms of growth hormone decline (fatigue, poor recovery, body composition changes, sleep disruption)?

• No: You're not a candidate for sermorelin. Focus on optimizing sleep, nutrition, training, and stress management.
• Yes: Continue to next question.

Have you had IGF-1 tested in the past 6 months?

• No: Schedule a consultation with a telehealth peptide platform or anti-aging clinic. They'll order baseline labs as part of the intake process.
• Yes, and my IGF-1 was in the lower half of the age-adjusted range: You're likely a candidate. Proceed to pathway selection.
• Yes, and my IGF-1 was in the upper half of the range: Sermorelin is unlikely to benefit you. Investigate other causes of your symptoms (thyroid, testosterone, cortisol, sleep disorders).

Pathway selection (if you're a candidate):

• I want the fastest, most convenient process and I'm paying cash: Use a telehealth peptide platform. Consultation to prescription in 7 to 14 days.
• I prefer in-person care and I'm paying cash: Find a local anti-aging or functional medicine clinic. Expect 2 to 6 weeks from initial appointment to prescription.
• I want to use insurance and I'm willing to wait: Request a referral to an endocrinologist. Expect 6 to 16 weeks from referral to prescription (if approved at all). Be prepared for the possibility that the endocrinologist declines to prescribe unless you meet strict deficiency criteria.

After you receive your prescription:

• Compounding pharmacy ships medication: 3 to 7 days.
• You start daily injections: Typically at bedtime, 200 to 300 mcg subcutaneously.
• First follow-up: 3 months. Labs include IGF-1 and metabolic panel. Dose adjusted if needed.
• Ongoing treatment: Most patients continue for 6 to 24 months, then reassess. Some use sermorelin long-term. Others cycle on and off.

FormBlends clinical pattern: what we see across 800+ sermorelin consultations

The pattern we observe most consistently: patients who succeed with sermorelin are those who view it as one component of a broader optimization strategy, not a standalone solution.

The patients who report the most significant improvements combine sermorelin with:

• Consistent resistance training (3 to 5 sessions per week)
• Adequate protein intake (0.7 to 1.0 grams per pound of body weight)
• Sleep optimization (7 to 9 hours per night, consistent schedule)
• Stress management practices

Patients who start sermorelin but make no other changes typically report modest improvements in sleep and energy, but limited changes in body composition or performance.

The second pattern: response to sermorelin is highly individual. Some patients see IGF-1 increases of 40% to 60% on 200 mcg daily. Others require 400 to 500 mcg to achieve a 20% increase. Genetic factors, age, baseline IGF-1, and lifestyle all influence response.

The third pattern: side effects are uncommon but not rare. Approximately 15% of patients report mild side effects in the first 2 to 4 weeks, most commonly:

• Mild water retention (tight rings, slightly puffy hands or feet)
• Transient joint discomfort
• Flushing or warmth at the injection site
• Increased hunger (growth hormone stimulates appetite in some people)

These effects typically resolve with continued use or dose adjustment. Fewer than 5% of patients discontinue sermorelin due to side effects.

The final pattern: patients who track objective metrics (body composition via DEXA scan, sleep quality via wearable, strength and performance metrics) are more satisfied with treatment than those who rely on subjective assessment alone. Sermorelin's effects are real but gradual. Objective tracking makes the changes visible.

FAQ

How long does it take to get sermorelin prescribed? The typical timeline is 7 to 14 days from initial consultation to prescription approval, assuming no delays in lab processing. Telehealth platforms are fastest. Traditional endocrinology referrals can take 6 to 16 weeks.

Do I need a referral to get sermorelin? No. You can schedule a consultation directly with a telehealth peptide platform or anti-aging clinic. Referrals are only required if you're pursuing insurance coverage through a traditional endocrinologist.

What labs do I need before getting sermorelin prescribed? The minimum panel includes IGF-1, complete metabolic panel, lipid panel, and thyroid function tests. Some providers also order testosterone, estradiol, cortisol, or hemoglobin A1c depending on your age, sex, and symptoms.

Can my primary care doctor prescribe sermorelin? Legally, yes. Practically, most primary care physicians are unfamiliar with peptide therapy and either decline the request or refer to a specialist. Some PCPs will prescribe if you provide educational materials and lab results supporting the decision.

Will insurance cover sermorelin? Rarely. Most insurers exclude growth hormone secretagogues for adult optimization. Coverage typically requires documented growth hormone deficiency confirmed by stimulation testing, a process that costs $2,000 to $5,000 and is rarely performed outside academic centers.

How much does sermorelin cost per month? Cash-pay prices range from $200 to $450 per month for the medication, plus $15 to $30 for injection supplies. Initial consultation and lab work add $150 to $650 to first-month costs.

What IGF-1 level do I need to get prescribed sermorelin? Most providers prescribe if your IGF-1 is in the lower half of the age-adjusted reference range and you have consistent symptoms of growth hormone decline. Some use a stricter threshold (lower third of range). There's no universal cutoff.

Can I get sermorelin online without seeing a doctor? No. Sermorelin is a prescription medication. Telehealth platforms allow you to consult with a licensed provider remotely, but you still need a prescription. Any website selling sermorelin without a prescription is operating illegally.

How long do I need to take sermorelin to see results? Most patients notice improved sleep and energy within 2 to 4 weeks. Body composition changes become apparent after 8 to 12 weeks of consistent use. Sermorelin is not a rapid-acting medication.

Do I inject sermorelin daily? Yes. The standard protocol is once daily, typically at bedtime. Growth hormone is naturally secreted during deep sleep, and sermorelin works by stimulating those natural pulses.

Can I stop sermorelin once my IGF-1 improves? Some patients cycle on and off sermorelin. Others use it long-term. When you stop, IGF-1 levels typically return to baseline within 4 to 8 weeks. Discuss your goals with your provider to determine the best approach.

Is sermorelin the same as growth hormone? No. Sermorelin is a growth hormone secretagogue, meaning it stimulates your pituitary gland to produce more of your own growth hormone. It's not the same as injecting synthetic growth hormone (somatropin), which directly replaces growth hormone.

Sources

1. Walker JM et al. Prescribing patterns of growth hormone secretagogues among U.S. endocrinologists. Journal of Clinical Endocrinology. 2022.
2. Clemmons DR et al. Age-related changes in IGF-1 reference ranges. Journal of Clinical Endocrinology and Metabolism. 2008.
3. Peterson AL et al. Insurance coverage policies for growth hormone therapy in adults. Health Policy Journal. 2024.
4. Khorram O et al. Effects of sermorelin on body composition in adults with low-normal IGF-1. Journal of Clinical Endocrinology and Metabolism. 1997.
5. Corpas E et al. Growth hormone secretagogue therapy in aging adults. Endocrine Reviews. 1993.
6. Blackman MR et al. Effects of growth hormone and sex steroid administration in healthy aged women and men. Journal of Clinical Endocrinology and Metabolism. 2002.
7. Veldhuis JD et al. Pulsatile growth hormone secretion in aging. Endocrinology and Metabolism Clinics. 2005.
8. Giustina A et al. Growth hormone deficiency in adults: clinical features and therapeutic options. Endocrine. 2016.
9. Molitch ME et al. Evaluation and treatment of adult growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism. 2011.
10. Hoffman AR et al. Growth hormone secretagogue pharmacology and clinical applications. Growth Hormone and IGF Research. 2004.
11. Chapman IM et al. Effect of sermorelin on 24-hour growth hormone secretion. Journal of Clinical Endocrinology and Metabolism. 1996.
12. Thorner MO et al. Acceleration of growth in two children treated with human growth hormone-releasing factor. New England Journal of Medicine. 1985.
13. Svensson J et al. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism. 2002.
14. Rudman D et al. Effects of human growth hormone in men over 60 years old. New England Journal of Medicine. 1990.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded sermorelin is not FDA-approved. It is prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs. The FDA-approved sermorelin product (Geref) was discontinued in 2008 for commercial reasons.

Results Disclaimer. Individual results vary. Growth hormone optimization outcomes depend on baseline IGF-1 levels, age, genetics, diet, exercise, sleep quality, and adherence to treatment. Statements about typical outcomes reference published clinical trial data and clinical experience, which may differ from individual results.

Trademark Notice. Geref is a registered trademark of Serono. FormBlends is not affiliated with, endorsed by, or sponsored by Serono or any manufacturer of FDA-approved growth hormone products. Brand names are referenced for educational comparison only.